Cases of gonorrhoea that are resistant to antibiotics are on the rise in England, with fears that the ‘super’ STI could soon ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...

The new antibiotic developed by GSK attacks a different part of the bacteria than other drugs, making it more effective ...

Health officials have warned of rising antibiotic-resistant gonorrhoea cases, including extensively drug-resistant strains.

A paper by a team of faculty members from the Jacobs School of Medicine and Biomedical Sciences and Roswell Park Comprehensive Cancer Center continues to garner outstanding recognition as it has ...

A rise in antibiotic resistant cases of gonorrhoea, including extensively drug resistant (XDR) strains, risks making the sexually transmitted infection (STI) “untreatable” if the problem is not ...

An international cost-effectiveness study, led by researchers at the UNC School of Medicine and the Kinshasa School of Public ...

The Aquahem Project, promoting sustainable aquaculture ecosystem management in West Africa, has organised a seminar to ...

The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...

New insights into a "friendly virus" that could pave the way for cutting-edge treatments for the potentially fatal superbug C ...

GSK’s oral antibiotic Blujepa (gepotidacin) has been approved by the US Food and Drug Administration (FDA) to treat ...